1,671
Views
14
CrossRef citations to date
0
Altmetric
Articles

Effects of puerarin on the pharmacokinetics of triptolide in rats

, , , , &
Pages 407-411 | Received 02 Apr 2019, Accepted 26 May 2019, Published online: 22 Jun 2019

References

  • Brinker AM, Raskin I. 2005. Determination of triptolide in root extracts of Tripterygium wilfordii by solid-phase extraction and reverse-phase high-performance liquid chromatography. J Chromatogr A. 1070:65–70.
  • Cheng S, LeBlanc KJ, Li L. 2014. Triptolide preserves cognitive function and reduces neuropathology in a mouse model of Alzheimer's disease. PLoS One. 9:e108845.
  • Choo MK, Park EK, Yoon HK, Kim DH. 2002. Antithrombotic and antiallergic activities of daidzein, a metabolite of puerarin and daidzin produced by human intestinal microflora. Biol Pharm Bull. 25:1328–1332.
  • Guo YJ, Liang DL, Xu ZS, Ye Q. 2014. In vivo inhibitory effects of puerarin on selected rat cytochrome P450 isoenzymes. Die Pharmazie. 69:367–370.
  • Hu YP, Tan ZJ, Wu XS, Liu TY, Jiang L, Bao RF, Shu YJ, Li ML, Weng H, Ding Q, et al. 2014. Triptolide induces S phase arrest and apoptosis in gallbladder cancer cells. Molecules. 19:2612–2628.
  • Huang F, Liu K, Du H, Kou J, Liu B. 2012. Puerarin attenuates endothelial insulin resistance through inhibition of inflammatory response in an IKKbeta/IRS-1-dependent manner. Biochimie. 94:1143–1150.
  • Jin MC, Chen XH, OuYang XK. 2009. Simultaneous determination of triptolide, tripdiolide and tripterine in human urine by high-performance liquid chromatography coupled with ion trap atmospheric-pressure chemical ionization mass spectrometry. Biomed Chromatogr. 23:289–294.
  • Kim SB, Yoon IS, Kim KS, Cho SJ, Kim YS, Cho HJ, Chung SJ, Chong S, Kim DD. 2014. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism. Planta Med. 80:561–567.
  • Li XJ, Jiang ZZ, Zhang LY. 2014. Triptolide: progress on research in pharmacodynamics and toxicology. J Ethnopharmacol. 155:67–79.
  • Liao ZG, Liang XL, Zhu JY, Zhao GW, Guan YM, Cao YC, Zhao LJ. 2014. Transport properties of puerarin and effect of extract of Radix Angelicae dahuricae on puerarin intestinal absorption using in situ and in vitro models. Phytother Res. 28:1288–1294.
  • Ling D, Xia H, Park W, Hackett MJ, Song C, Na K, Hui KM, Hyeon T. 2014. pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma. ACS Nano. 8:8027–8039.
  • Liu CM, Ma JQ, Sun YZ. 2011a. Protective role of puerarin on lead-induced alterations of the hepatic glutathione antioxidant system and hyperlipidemia in rats. Food Chem Toxicol. 49:3119–3127.
  • Liu L, Li P, Qiao L, Li X. 2018. Effects of astragaloside IV on the pharmacokinetics of puerarin in rats. Xenobiotica. 1–12.
  • Liu Z, Ma L, Zhou GB. 2011b. The main anticancer bullets of the Chinese medicinal herb, thunder god vine. Molecules (Basel, Switzerland). 16:5283–5297.
  • Singla N, Challana S. 2014. Reproductive toxicity of triptolide in male house rat, Rattus rattus. Scientific World Journal. 2014:879405.
  • Su P, Cheng Q, Wang X, Cheng X, Zhang M, Tong Y, Li F, Gao W, Huang L. 2014. Characterization of eight terpenoids from tissue cultures of the Chinese herbal plant, Tripterygium wilfordii, by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Biomed Chromatogr. 28:1183–1192.
  • Wang BY, Cao J, Chen JW, Liu QY. 2014. Triptolide induces apoptosis of gastric cancer cells via inhibiting the overexpression of MDM2. Med Oncol (Northwood, London, England). 31:270.
  • Wang X, Zhang X, Liu F, Wang M, Qin S. 2017. The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism. Pharm Biol. 55:1863–1867.
  • Wei D, Huang Z. 2014. Anti-inflammatory effects of triptolide in LPS-induced acute lung injury in mice. Inflammation. 37:1307–1316.
  • Wong KH, Li GQ, Li KM, Razmovski-Naumovski V, Chan K. 2011. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol. 134:584–607.
  • Yan G, Zhang H, Wang W, Li Y, Mao C, Fang M, Yi X, Zhang J. 2017. Investigation of the influence of glycyrrhizin on the pharmacokinetics of celastrol in rats using LC–MS and its potential mechanism. Xenobiotica. 47:607–613.
  • Yeung DK, Leung SW, Xu YC, Vanhoutte PM, Man RY. 2006. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol. 552:105–111.
  • Zhang H, Zhang L, Zhang Q, Yang X, Yu J, Shun S, Wu Y, Zeng Q, Wang T. 2011. Puerarin: a novel antagonist to inward rectifier potassium channel (IK1). Mol Cell Biochem. 352:117–123.
  • Zhang MF, Liu YX, Jiang KY, Niu HM, Jiang JL, Dong ST, Wang X, Wang DF, Meng SN. 2019. Alteration of UDP-glucuronosyltransferase 1a1, 1a7 and P-glycoprotein expression in hepatic fibrosis rats and the impact on pharmacokinetics of puerarin. Phytomedicine. 52:264–271.
  • Zhang Y, Li J, Lei X, Zhang T, Liu G, Yang M, Liu M. 2016. Influence of verapamil on pharmacokinetics of triptolide in rats. Eur J Drug Metabol Pharm. 41:449–456.
  • Zhao Q, Wang Y, Wang H, Feng L. 2018. Effects of glycyrrhizin on the pharmacokinetics of puerarin in rats. Xenobiotica. 48:1157–1163.
  • Zhou Y, Song X, Dong G. 2018. Effects of verapamil on the pharmacokinetics of puerarin in rats. Xenobiotica. DOI:10.1080/00498254.2018.1518552.